Entries by Kara Rayburn

AML Research Updates: News from ASH 2020

AML expert Dr. Jeffrey Lancet shares news from the 2020 American Society of Hematology (ASH) annual meeting. Dr. Lancet sheds light on headlines from the meeting including FLT3 inhibitor research, […]

Is the COVID-19 Vaccine Safe for Myeloma Patients?

Is the COVID-19 Vaccine Safe for Myeloma Patients? from Patient Empowerment Network on Vimeo.  Should myeloma patients get the COVID-19 Vaccine? Dr. Joshua Richter encourages all patients to get the […]

Myeloma Treatment Decisions: What Should Be Considered?

Myeloma Treatment Decisions: What Should Be Considered? from Patient Empowerment Network on Vimeo. When deciding on a myeloma treatment, what factors affect your choice? Dr. Joshua Richter shares key considerations, […]

What Standard Testing Follows a Myeloma Diagnosis?

What Standard Testing Follows a Myeloma Diagnosis? from Patient Empowerment Network on Vimeo.  What tests will you have following a myeloma diagnosis? Are there additional tests you should request? Dr. […]

How Molecular Testing Has Transformed AML Treatment Options

How Molecular Testing Has Transformed AML Treatment Options from Patient Empowerment Network on Vimeo. How has molecular testing impacted approaches to acute myeloid leukemia (AML) therapy? Dr. David Sallman explains […]

Treatment Advances for Aging AML Patients

Treatment Advances for Aging AML Patients from Patient Empowerment Network on Vimeo. What are the latest acute myeloid leukemia (AML) treatment advances for elderly patients? Dr. David Sallman shares details […]